Protect Access to Medicines and Oppose HF 17 / SF 168
The Minnesota legislature is considering legislation (HF 17 and SF 168) that would create a so-called “prescription drug affordability board.” This legislation threatens patients and future biopharmaceutical research and development. Please contact your state legislators now by filling out the form and urge them oppose these bills.